Transmissible spongiform encephalopathies (TSEs), including scrapie in sheep (Ovis aries), are fatal neurodegenerative diseases caused by the misfolding of the cellular prion protein (PrP C ) into a â-rich conformer (PrP Sc ) that accumulates into higher-order structures in the brain and other tissues. Distinct strains of TSEs exist, characterized by different pathologic profiles upon passage into rodents and representing distinct conformations of PrP Sc . One biochemical method of distinguishing strains is the stability of PrP Sc as determined by unfolding in guanidine hydrochloride (GdnHCl), which is tightly and positively correlated with the incubation time of disease upon passage into mice. Here, we utilize a rapid, protease-free version of the stability assay to characterize naturally occurring scrapie samples, including a fast-acting scrapie inoculum for which incubation time is highly dependent on the amino acid at codon 136 of the prion protein. We utilize the stability methodology to identify the presence of two distinct isolates in the inoculum, and compare isolate properties to those of a host-stabilized reference scrapie isolate (NADC 13-7) in order to assess the stability/incubation time correlation in a natural host system. We demonstrate the utility of the stability methodology in characterizing TSE isolates throughout serial passage in livestock, which is applicable to a range of natural host systems, including strains of bovine spongiform encephalopathy and chronic wasting disease.
Introduction
Prion diseases, including bovine spongiform encephalopathy (BSE) in cattle, scrapie in sheep and goats, chronic wasting disease (CWD) in cervids, and Creutzfeldt-Jakob disease (CJD) in humans, are neurodegenerative diseases that manifest as behavioral changes and/or neurological signs and eventually progress to death. Also known as transmissible spongiform encephalopathies (TSEs), prion diseases are caused by misfolding of the cellular, protease-sensitive prion protein (PrP C ) into an infectious, more protease-resistant form (PrP Sc ) that accumulates in the nervous system and certain other body tissues.
Incubation time and susceptibility of animals to natural prion disease are affected by sequence variations in the prion gene (PRNP). In sheep, the presence of valine (V; as opposed to alanine, A) at codon 136 and the presence of glutamine (Q; as opposed to arginine, R) at codon 171 of the prion protein are associated with scrapie susceptibility [1, 2, 3, 4] . The capacity of (infectious) PrP Sc to induce conformational changes in host PrP C molecules varies depending on the host PrP amino acid sequence [5] . For example, the recombinant V 136 Q 171 sheep prion protein has a higher intrinsic stability (which could lead to a lower PrP clearance rate in the cell), more compact structure, and a more â-rich folding intermediate than observed for recombinant PrP of more scrapieresistant genotypes [6, 7] . Therefore, it is proposed that these properties are the molecular basis of differential scrapie susceptibility [7] . However, how the stability of the recombinant PrP (a model for cellular PrP C ) correlates with the stability of the diseaseassociated PrP Sc structures in the brain is not well-characterized. Distinct strains of TSEs have been demonstrated to exist, manifesting as differences in the incubation period and in the profile of lesions and PrP Sc accumulation in the brain upon experimental transmission to rodent hosts [8, 9, 10] . Based on the ''protein only'' hypothesis of prion infectivity [11] , these strain properties must be the result of differences in the structure of PrP Sc , since the PrP amino acid sequence would be the same in each host [12, 13] . The structure of the PrP Sc strain in the inoculum would be transmitted upon conversion of host PrP C to PrP Sc [14] . While over 20 different strains of sheep scrapie have been identified in the UK, the diversity of strains present in the US sheep population is not as well-characterized [15] , and the level of diversity may be underestimated by the standard, non-transgenic mouse bioassay [16] . Since sheep hosts of different PRNP genotypes differ in their level of susceptibility to isolates of scrapie [1] , and scrapie eradication efforts are based on breeding genetics, a better understanding of the properties of the different strains will enhance options for control and eradication of scrapie.
While rodent infection studies are the ''gold standard'' for strain characterization, prion strains can also be differentiated biochemically. Strains may exhibit differences in the profile of glycosylated, proteinase K (PK)-digested PrP Sc isoforms as detected on a Western blot [17] . Alternatively, strains can be characterized by their stability as determined by denaturant unfolding using guanidine hydrochloride (GdnHCl) [12] . To measure stability, infected brain homogenate (BH) or enriched PrP Sc is incubated with increasing concentrations of GdnHCl, and the level of PrP Sc remaining is measured by methods such as PK digestion (unfolded PrP Sc is degraded by the PK treatment along with the PrP C ) coupled to Western blotting or ELISA; the conformationdependent immunoassay [18] ; or a method that quantitates changes in PrP Sc solubility by centrifugation and Western blotting [19] . Here, we utilize a commercial ELISA (IDEXX HerdChek) with a non-antibody capture surface that binds PrP Sc (but not PrP C or unfolded PrP) to monitor the fraction of PrP Sc remaining at each [GdnHCl] . This assay is denoted here as a ''stability assay''; however, we are monitoring the irreversible denaturation of PrP Sc [12] , and the assay does not yield thermodynamic parameters for the unfolding process. Whether the assay is assessing loss of tertiary structure of PrP Sc , disruption of quaternary structure, or both is not known [20] . PrP Sc stability is quantified as the GdnHCl concentration leading to halfmaximal denaturation of the protein complexes ([GdnHCl] 1/2 ).
The incubation time of prion strains intracranially (IC) inoculated into mice is directly correlated with the stability of PrP Sc recovered from infected mouse brain, as measured by a version of the assay described above [20] . Lower stability has been linked to shorter sizes of mammalian PrP Sc fibrils; thus, it is proposed that low stability leads to increased PrP Sc fibril fragmentation, which decreases incubation times by facilitating the PrP C PrP Sc conversion [21, 22] . In contrast, hamster-adapted prion strains exhibit an opposite relationship, with short incubation times correlated with higher conformational stability; the short incubation time hamster strains are associated with decreased clearance from neurons [18, 23] . The stability assay has primarily been utilized to characterize rodent-passaged strains (of natural or synthetic prions; [20, 24] ) or CJD PrP Sc [25, 26] , although recent studies have demonstrated a large difference in stability between atypical/Nor98 scrapie and classical scrapie in naturally infected sheep [19, 27] .
Here, we utilized the ELISA-based stability assay to consider the relationships between PrP Sc stability, incubation time, and host genotype in a natural host system for prion disease: sheep (Ovis aries) experimentally infected with classical scrapie. We characterized PrP
Sc from sheep infected with a fast-acting scrapie inoculum exhibiting host PRNP (codon 136) genotype dependence on incubation time, using the stability assay to provide molecular evidence for two separate isolates of scrapie and to compare their properties to those of a representative scrapie isolate (NADC 13-7). In addition, we use the stability approach to characterize the molecular properties of field scrapie PrP Sc through the process of strain stabilization over the course of four serial passages in sheep. Table 1 ). An AV 136 QR 171 sheep was also susceptible to x124 IC infection with an incubation time of only 5.6 months [30] , despite the fact that QR 171 sheep are thought to be highly resistant to scrapie infection [2] . (Note that incubation times of scrapie in ICinfected sheep are shorter than incubation times in orally infected sheep; [29] ).
Results and Discussion
We examined the appearances of the x124-infected, PKdigested AA 136 , AV 136 , and VV 136 PrP Sc on a Western blot probed with P4 primary antibody (Fig. 1A, right panel) ; consistent with the previously published results, the Western blotting pattern of PK-digested PrP Sc was not genotype-dependent [30] . We additionally observed that PrP Sc from each genotype reacted with both P4 and L42, consistent with sheep classical scrapie strains as opposed to sheep BSE (Fig. 1A, left panel) . AA 136 and VV 136 PrP Sc exhibited similar tolerance to digestion with concentrations of PK ranging from 5 to 100 mg/ml (data not shown).
As an initial comparison of the stability of PrP Sc in x124-infected sheep of each genotype, sheep brainstem samples were treated with either 0.1 or 4 M GdnHCl, and the amount of PrP Sc remaining after PK digestion was examined by Western blot (Fig. 1B) Fig. 1C .
To better quantitate this effect, we used the HerdChek ELISA to directly measure the level of PrP Sc remaining after treatment with increasing concentrations of GdnHCl ( Fig. 2A) . This version of the stability assay is more time-effective than other methods; after treatment with GdnHCl, only a simple dilution step is required before the ELISA, which can be completed in less than a day (a post-dilution [GdnHCl] of 0.25 M was selected as a compromise between the sample dilution factor and the ELISA signal; see Methods). Importantly, by avoiding a PK digestion step, this version of the ELISA-based stability assay provides a complete picture of the PrP Sc present in the sheep brain, including PrP Sc that is more protease-sensitive (if present; [31] ). Similarly, we utilize the entire population of PrP Sc in the PBS-homogenized brainstem tissue, as opposed to an enriched/purified fraction that may exclude certain populations of PrP Sc , such as lower-molecular weight aggregates that may not pellet during centrifugation. For AV 136 and VV 136 brain homogenates, the amount of PrP Sc remaining plotted against the GdnHCl concentration approximated a sigmoidal curve (as described for mouse brain PrP Sc ; [20] ) with an average [GdnHCl] 1/2 (6 standard error of the mean) of 2.4 M 60.02 for V 136 -containing sheep (n = 4 biological replicates). In contrast, the AA 136 PrP Sc was significantly more stable, with an estimated [GdnHCl] 1/2 of 3.8 M 60.1 overall (n = 5 biological replicates; value is estimated due to the high stability of the samples and the technical parameters of the assay). The unfolding curve of AV 136 matched that of VV 136 PrP Sc when compared in more detail at the transition region of the curve (Fig. 2B) . Based on the VV 136 vs. AA 136 difference observed in Fig. 2A , we hypothesize that only the V 136 PrP in the heterozygous brains is converted to PrP Sc , and that the slightly longer incubation time of the AV 136 versus VV 136 sheep (Table 1) is due to the lower concentration of V 136 PrP available in the brain for conversion. This is consistent with the findings of Jacobs et al. [32] for the conversion of only the V 136 Q 171 PrP C to PrP Sc in AV 136 QR 171 sheep. Therefore, on the first passage, relative stability was correlated with the incubation times that were in turn correlated with the genotypes.
We observed that the concentration of GdnHCl required in the more stable cases exceeded the buffering capacity of the PBS solution, resulting in a reduction in the final pH of samples as the [GdnHCl] was increased. Based on this observation, we compared unfolding curves for AA 136 and VV 136 PrP Sc generated by the above method to curves generated with GdnHCl solution that had been adjusted to a neutral pH (Fig. 2C ). We observed a pH-dependent change in the profile at 3-4 M GdnHCl (with an increased ELISA signal for acidic samples), but the difference in stability profile between AA 136 and VV 136 animals was observed with both methods. To examine the source of the pH effect on the ELISA signal, we treated 1 ml BH with 9 ml PBS adjusted to pH<4 (treatment #1) or with PBS pH 7.4 (treatment #2) for 1 hour in the absence of GdnHCl. After dilution of samples with PBS (pH 7.4) up to 160 ml total volume, as in the above assays, we did not observe that treatment with acid increased the ELISA signal; instead, the signal was very slightly decreased in treatment 1 as compared to treatment 2. This result confirms that it is the pH in the presence of the GdnHCl that impacts the process of irreversible denaturation (here, reducing the level of denaturation at low pH). This observation is an important technical note for future studies of highly stable strains, as 1X PBS buffer is frequently used for preparation and testing of tissue homogenates.
Observed Stability Differences are not Due to Inherent Effects of PrP Sc Amino Acid Sequence
The observed difference in stability between the x124-infected AA 136 and VV 136 sheep PrP Sc could be explained by two hypotheses: either (1) the stability of the host scrapie PrP Sc formed from a singleisolate in the x124 inoculum is host genotypedependent, or (2) multiple, distinct isolates of scrapie were present in the flock that served as the source of the scrapie inoculum (and the AA 136 sheep brains predominantly accumulated a different isolate than did the other sheep). In order to examine if there is an effect of host protein amino acid sequence on the stability of PrP Sc , we utilized samples of sheep brainstem experimentally infected with the same classical scrapie isolate, NADC 13-7 (more details in Methods; Table 1 ). The ability to compare samples that have been infected with a single isolate of host-stabilized scrapie provides a superior system to analysis of field samples of different genotypes, which may be infected with different, or mixed, strains/isolates. The stability of PrP Sc from 13-7 infected AA 136 sheep (#14, #15, #20) and the stability of PrP Sc from 13-7 infected VV 136 sheep (#12, #13) were compared. Despite apparent differences in the incubation time of the two AV 136 and the two VV 136 animals (Table 1) , we did not observe differences in the stability of PrP Sc from the two different host genotypes at the level of resolution of this assay (Fig. 3A) . This result also demonstrates the potential use of this methodology for comparisons of the effects of PRNP polymorphisms on PrP Sc properties in natural hosts.
Identification of Distinct Scrapie Strains in the Genotypedependent x124 Scrapie Inoculum
The results of the 13-7-infected host comparison suggest that the data in Fig. 2A could alternatively Sc from x124-infected sheep is consistent with reports that classical field scrapie samples are stable up to 3-4 M GdnHCl as measured by PKWestern dot blot [27] .
Note that while the stability of their PrP Sc was low, the incubation times for sheep #10 and #11 (AA 136 ) were relatively long; VV 136 sheep infected with the same dose of brain #3004 intranasally (a slower-onset method of inoculation) succumbed to scrapie in less than half the time in the same experiment (Table 1) . We attribute this to a host PrP C genotype influence on disease kinetics, an effect that must supersede the role of PrP Sc complex stability in determining incubation time in this case. As compared to inoculation studies of isogenic mouse hosts, explorations of incubation time relationships in livestock must take into consideration the role of both host (PrP C ) genotype and PrP Sc stability.
Molecular Typing of Serially Passaged US Scrapie Inoculum 13-7
The results of this study demonstrate the utility of the stability assay in distinguishing between prion isolates which have apparently identical Western blot profiles. Often, prion isolates are serially passaged in order to select and stabilize an isolate. As an additional application of the ELISA-based stability assay to livestock systems, we used stability profiles to investigate the composition of PrP Sc from sheep brains during serial passage of the 13-7 strain. In previous work [33] , the initial 13-7 pooled brain inoculum (pool of 13 sheep brains from 7 different flocks) was used to IC infect 5 different Suffolk lambs (all AA 136 ); incubation times before development of clinical symptoms varied between 13 and nearly 24 months (Fig. 3C) . For each passage, BH (1 ml of a 10% w/v brain suspension) from the sheep with the shortest incubation time was used to inoculate the lambs in the subsequent passage [33] ; average incubation times for each passage were Passage 1 (P1) = 19.0 mo., P2 = 10.3 mo, P3 = 12.1 mo., and P4 = 10.7 mo. We determined the stability of PrP Sc from selected lambs from each passage to determine if the relative [GdnHCl] 1/2 tracked with the incubation time of the sheep (Fig. 3B ). Significant differences in the incubation time of sheep at the first passage and the incubation time at later passages were present, suggesting stabilization of the isolate subsequent to the first passage (P-values were 0.0007, 0.003, and 0.001 when comparing passage 1 incubation time with incubation time of each of the subsequent passages (P2-P4), respectively). However, we did not observe a relationship between the incubation time of the sheep and the [GdnHCl] 1/2 . While we observe some variations in the upper baseline, the rest of the curve is very similar for the different samples (Fig. 3B) . This result is consistent with the fact that the lesion profiles and PrP Sc immunohistochemistry (IHC) patterns in brain sections did not differ between subpassage groups [33] . It is possible that multiple isolates were present in the original inoculum, but the data suggests that on the first passage, the predominant isolate in each of the infected sheep was the same. This in turn suggests that other factors besides the specific isolate of scrapie that is present influenced the incubation time and caused the decrease in incubation time between the first and the subsequent passages. One possibility is that dosage of the predominant scrapie isolate increased upon passage. While we did not observe differences in PrP Sc stability in this case study, we note that this would be a useful and rapid method for directly tracking prion isolates in other livestock prion stabilization studies.
Correlation between PrP
Sc Stability and Incubation Time in a Natural Host System
As discussed, in two independent experimental inoculations of sheep with homogenate containing 136-VDEP [28, 30] , rapid disease progression was observed in sheep carrying at least one V 136 allele. Similar rapid disease development (incubation times of <7 months for VV 136 animals) was observed upon intranasal inoculation of AV 136 and VV 136 sheep with a brain from a single 136-VDEP-infected AV 136 QR 171 animal (Table 1 ). In the same study, sheep intranasally infected with (stabilized) 13-7, serving as a reference isolate of U.S. sheep scrapie, progressed to disease in an average of 22 months, in a codon 136 genotype-independent fashion (Table 1) . We suggest that the dose of 13-7 in this study was overwhelming since 100% (4/4) of the inoculated sheep developed clinical signs and accumulation of brainstem PrP Sc due to inoculation with this passaged and host-adapted strain (Table 1 , sample #'s 12-15). Therefore, experimental evidence combined over multiple studies in sheep suggests that the incubation time of the stabilized 13-7 isolate is longer than that of the 136-VDEP isolate (which has an unusually short incubation time for classical scrapie in sheep).
We utilized PrP Sc stability information from the experiments described above to determine if the 13-7 and 136-VDEP isolates also exhibited a significant difference in stability. Unfolding curves from Fig. 3A and Fig. 3B (excluding the first passage in Fig. 3B ; n = 8) were averaged to generate a 13-7 unfolding curve, and (pHcontrolled) unfolding curves from AV 136 and VV 136 sheep (n = 4) were averaged to generate a 136-VDEP unfolding curve (Fig. 3D) . The shorter incubation time of 136-VDEP in sheep correlates with a lower stability (lower [GdnHCl] 1/2 value), suggesting that the correlation between incubation time and PrP Sc stability observed in mouse-passaged samples [20] may also apply to natural hosts. We note that the incubation time and stability also appear to be correlated for the isolate present in the x124-infected AA 136 sheep (average of 19 months for the IC samples investigated here, [GdnHCl] 1/2 .3; compared to an average of 5 months for the ICinoculated VV 136 sheep for 136-VDEP and an average of 11 months for IC-inoculated AA 136 sheep for 13-7; [33] and Table 1 ). However, it is possible that the x124 inoculum, which also carried the 136-VDEP isolate, only carried a low dose of the higherstability isolate. Further experimentation, in which x124-infected AA 136 brain homogenate is passaged into additional sheep, is warranted to confirm the incubation time upon use of a higher dose. Interestingly, Bulgin et al. [28] report that the 136-VDEP isolate in orally-infected AV 136 sheep led to an abnormally fine, ''sprinkled'' accumulation of PrP Sc throughout the affected tissues. Therefore, it is possible that the relationship between diffuse aggregation, low PrP Sc stability, and short incubation times observed in mice [34] also applies to strains of classical scrapie in the natural host. However, we note that in contrast, Hamir et al. In summary, we demonstrate the utility of the ELISA-based GdnHCl stability assay in the analysis of prion disease isolates (otherwise indistinguishable by the standard Western blotting test) in natural hosts. The commercial, non-PK-dependent ELISA utilized here is particularly simple and rapid for use in these measurements. We identify the presence of a mixture of isolates in an inoculum previously believed to reflect a single isolate of scrapie [30] and characterize field scrapie samples across the process of serial passage in sheep. We demonstrate that the short-incubation ''136-VDEP'' isolate is associated with an unstable PrP Sc higher structure as compared to the longer-incubation, higher stability scrapie isolate13-7, analogous to the previously reported correlation in mouse-adapted strains [20] . The second passage of the 136-VDEP isolate into AA 136 animals highlights the role of host genotype in this incubation time/stability correlation. Finally, we do not identify differences in the inherent stability of A 136 PrP Sc and V 136 PrP Sc (when infected by the same host-stabilizedprion isolate) in this assay of irreversible denaturation. The approach presented here is broadly applicable to naturally occurring TSEs in natural host species (with different PrP primary structure), and this work will inform future experiments designed to further our understanding of livestock TSE incubation time, genotype, and stability relationships.
Materials and Methods

Ethics Statement
All animal studies were carried out in accordance with the Guide for the Care and 
Sheep Brain Sample Sources
Scrapie-infected sheep brain samples were obtained from previous studies [28, 30, 33, 35] or ongoing pathogenesis studies at the National Animal Disease Center (protocol #3893). Briefly, x124-infected samples [30] (Table 1 ; all animals were RR 154 QQ 171 ) were IC inoculated as lambs with the x124 inoculum, prepared from a pool of 7 scrapie-affected brains from animals that were QQ 171 and either AA (n = 5), AV (n = 1), or VV (n = 1) at codon 136. Animals were allowed to progress to the incidence of clinical disease, euthanized, and necropsied upon incidence of clinical signs; the presence of PrP Sc in the brain was confirmed by Western blotting and IHC [30, 35] . Sheep #3004 (AV 136 QR 171 ) was orally inoculated with x124 (5ml of a 5% brain homogenate) and similarly treated [28] .
For the comparison of 136-VDEP and (stabilized) 13-7 infection of sheep, lambs were intranasally (IN) inoculated with 1 ml of either 13-7 (derived from a single brain carrying the 13-7 isolate after stabilization via 4 passages in sheep) or 136-VDEP (derived from sheep brain #3004, as described) BH. Animals were euthanized upon development of clinical symptoms or at the end of the experiment (30 months). Two uninoculated control sheep did not develop clinical symptoms during the time frame of the experiment (sheep #22 and #23, Table 1 ).
Finally, samples for the molecular investigation of the serial passage of 13-7 in sheep were obtained from Hamir et al. [33] . Briefly, pooled BH denoted as ''13-7'' was prepared from 13 scrapie-infected sheep brains (derived from 7 different U.S. source flocks) and passaged in 4 generations of Suffolk lambs (predominantly AA 136 RR 154 QQ 171 ). The incubation time data for serial passage of scrapie isolate 13-7 was analyzed by analysis of variance using a general linear model for unbalanced data (SAS for Windows, Version 9.2, SAS Institute Inc.,Cary, NC, USA). A significance level of 5% was also used for comparisons between passages.
Preparation and Western Blotting of Sheep Brain Homogenates
Samples of the brainstem of sheep brains that had been frozen at 280uC or 220uC were used to prepare BH for Western blotting and ELISA analysis. Tissue samples were bead homogenized at 20% (w/v) in 16 PBS (Dulbecco's PBS, pH 7.4, lacking calcium and magnesium) and tested shortly after storage at 280uC. PK digestion of whole BH was performed in 1X PBS for 1 hr. at 37uC, at a final [PK] of 100 mg/ml, followed by inactivation of PK with 1 mM Pefabloc (Roche). Samples were boiled in 1x LDS loading dye (Invitrogen) and 5% â-mercaptoethanol and loaded to 12% NuPAGE Bis-Tris gels (MOPS running buffer, Invitrogen); samples were transferred to PVDF and membranes were blocked for 30 minutes in TBST (TrisBuffered Saline +0.1% Tween) +3% BSA. Membranes were successively probed with either the L42 or the P4 primary antibody (monoclonal mouse; 1:10,000 for P4, 1:500 for L42; overnight at 4uC), biotinylated sheep anti-mouse secondary antibody (1:10,000, 45 minutes, room temperature), and HRPconjugated streptavidin (1:10,000, 45 minutes, room temperature), all in TBST +3% BSA. Blots were imaged with ECL Plus reagent (Pierce) by either chemiluminescence or fluorescence on a GBOX instrument (Synoptics).
To perform the Western blots of GdnHCl-treated samples (Fig. 1B, C) , BH was incubated with 0.1 or 4 M GdnHCl (Fig. 1B) or concentrations of GdnHCl increasing to 4 M (Fig. 1C ) for 1 hour, followed by dilution of samples with 1X PBS to a final [GdnHCl] of 0.1 M. Diluted samples were PK-digested and treated with Pefabloc as described above, followed by overnight precipitation at 220uC by the addition of 3-4 volumes of acetone. After recovery of the precipitate by centrifugation, the pellet was boiled in loading buffer and subjected to Western blotting with P4 antibody as described above.
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